Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: introduction and overview.
Olestra is a mixture of polyesters formed from sucrose and fatty acids derived from edible fats and oils. It is not absorbed or digested and can serve as a zero-calorie replacement for dietary fat. Because olestra is lipophilic and not absorbed, it has the potential to interfere with the absorption of other dietary components, especially lipophilic ones, when it is in the digestive tract with those components. A series of studies were conducted in the domestic pig and in healthy adult humans to define the nature and extent of olestra's effect on fat-soluble vitamins, selected water-soluble micronutrients, and macronutrients, and to demonstrate that the effects of olestra on the absorption of fat-soluble vitamins can be offset by adding extra amounts of the affected vitamins to olestra foods. Before conducting the human and pig studies, the intake of olestra from the consumption of snack foods made with olestra was estimated for various subgroups. The potential for olestra to affect the absorption of nonessential but potentially beneficial dietary phytochemicals was also assessed. In addition, an assessment of how consumption patterns influence the effect of olestra on the absorption of the highly lipophilic carotenoids was made. Finally, the results from the pig and human studies were used to assess the potential for olestra to affect the nutritional status of subgroups of the population who have particularly high nutrient needs or unique dietary patterns that may lead to large olestra-to-nutrient intake ratios.
Peters
J C
JC
The Procter & Gamble Company, Winton Hill Technical Center, Cincinnati, OH 45224, USA.
Lawson
K D
KD
Middleton
S J
SJ
Triebwasser
K C
KC
D000328:Adult; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D004042:Dietary Fats, Unsaturated / Q000493:pharmacokinetics / Q000494:pharmacology*; D019358:Fat Substitutes / Q000493:pharmacokinetics / Q000494:pharmacology*; D005227:Fatty Acids / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D009747:Nutritional Physiological Phenomena; D013395:Sucrose / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D013552:Swine; D014815:Vitamins / Q000493:pharmacokinetics
D004042:Dietary Fats, Unsaturated; D019358:Fat Substitutes; D005227:Fatty Acids; D014815:Vitamins; D013395:Sucrose; C013692:sucrose polyester